We have located links that may give you full text access.
CLINICAL TRIAL
COMPARATIVE STUDY
JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
RESEARCH SUPPORT, NON-U.S. GOV'T
Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis.
Journal of Hepatology 1996 November
BACKGROUND/AIMS: There is now overwhelming evidence that hepatic stellate cells are the principal cells involved in hepatic fibrogenesis. In several different forms of liver injury it has been demonstrated that they proliferate and undergo phenotypic transformation (activation) into matrix-producing, myofibroblast-like cells in response to necroinflammation, mediated in part, by Kupffer cell-derived factors. In alcoholic liver disease, however, the observation that fibrosis can occur in the absence of alcoholic hepatitis has cast doubt on necroinflammation being an absolute pre-requisite for alcohol-related hepatic stellate cells proliferation/activation and subsequent fibrogenesis.
METHODS: Evidence for hepatic stellate cells activation has been sought in liver biopsies from 38 well-documented alcoholic patients with no evidence of alcoholic hepatitis or cirrhosis and eight normal controls. Activated hepatic stellate cells were identified immunohistochemically using a specific monoclonal antibody to detect cytoplasmic alpha smooth muscle actin (alpha-SMA), which is not present in quiescent cells. Kupffer cells were detected with the monoclonal antibody KP1 and collagen was stained using Sirius red. Immunoreactive cells and the amount of fibrosis were quantified, using a Kontron Vidas Image Analyser. Steatosis was graded from 0 (none-few hepatocytes containing fat) to 3 (> 2/3 hepatocyte containing fat).
RESULTS: Biopsies from alcoholic patients contained significantly greater numbers of activated hepatic stellate cells (alpha-SMA+ve) than control biopsies (average cell counts: 84 +/- 11/mm2 versus 23 +/- 5/mm2, p < 0.0001). There was no correlation between numbers of activated hepatic stellate cells and either numbers of Kupffer cells or amount of fibrosis. There was, however, a significant correlation between hepatic stellate cells activation and steatosis (grade 0, 15 +/- 7 cells/unit area (n = 4), grade 1, 56 +/- 16 (n = 13), grade 2, 85 +/- 20 (n = 9), grade 3, 137 +/- 19 (n = 12); p = 0.002, ANOVA).
CONCLUSIONS: These results suggest that neither necroinflammation nor an increase in Kupffer cells is an absolute prerequisite for hepatic stellate cells proliferation/activation and subsequent fibrogenesis in alcoholic liver disease. The correlation between alcohol-induced hepatic stellate cells activation and severity of steatosis is likely to reflect that both are attributable in part to the metabolic consequences of ethanol metabolism, namely increased concentrations of acetaldehyde and lipid peroxidation.
METHODS: Evidence for hepatic stellate cells activation has been sought in liver biopsies from 38 well-documented alcoholic patients with no evidence of alcoholic hepatitis or cirrhosis and eight normal controls. Activated hepatic stellate cells were identified immunohistochemically using a specific monoclonal antibody to detect cytoplasmic alpha smooth muscle actin (alpha-SMA), which is not present in quiescent cells. Kupffer cells were detected with the monoclonal antibody KP1 and collagen was stained using Sirius red. Immunoreactive cells and the amount of fibrosis were quantified, using a Kontron Vidas Image Analyser. Steatosis was graded from 0 (none-few hepatocytes containing fat) to 3 (> 2/3 hepatocyte containing fat).
RESULTS: Biopsies from alcoholic patients contained significantly greater numbers of activated hepatic stellate cells (alpha-SMA+ve) than control biopsies (average cell counts: 84 +/- 11/mm2 versus 23 +/- 5/mm2, p < 0.0001). There was no correlation between numbers of activated hepatic stellate cells and either numbers of Kupffer cells or amount of fibrosis. There was, however, a significant correlation between hepatic stellate cells activation and steatosis (grade 0, 15 +/- 7 cells/unit area (n = 4), grade 1, 56 +/- 16 (n = 13), grade 2, 85 +/- 20 (n = 9), grade 3, 137 +/- 19 (n = 12); p = 0.002, ANOVA).
CONCLUSIONS: These results suggest that neither necroinflammation nor an increase in Kupffer cells is an absolute prerequisite for hepatic stellate cells proliferation/activation and subsequent fibrogenesis in alcoholic liver disease. The correlation between alcohol-induced hepatic stellate cells activation and severity of steatosis is likely to reflect that both are attributable in part to the metabolic consequences of ethanol metabolism, namely increased concentrations of acetaldehyde and lipid peroxidation.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app